BIO-key International, Inc.
BKYI
$0.746
$0.0060.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.95% | 38.36% | 49.53% | 59.12% | 52.69% |
| Total Depreciation and Amortization | 7.02% | 8.40% | 11.12% | -5.35% | -20.60% |
| Total Amortization of Deferred Charges | 82.59% | 78.48% | 75.18% | -87.08% | -87.13% |
| Total Other Non-Cash Items | -96.67% | -102.07% | -102.08% | -82.08% | -56.88% |
| Change in Net Operating Assets | -167.77% | -117.24% | 933.49% | -225.53% | 716.83% |
| Cash from Operations | -24.25% | -158.15% | 23.18% | 5.56% | 53.26% |
| Capital Expenditure | -496.55% | -444.83% | -1,210.00% | 52.75% | 95.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -496.55% | -444.83% | -1,210.00% | 81.60% | 97.89% |
| Total Debt Issued | -100.00% | -- | -- | -0.10% | -0.10% |
| Total Debt Repaid | 61.25% | 61.07% | 60.65% | -757.66% | -1,007.10% |
| Issuance of Common Stock | 33.48% | 33.13% | -55.55% | 44,451.08% | 30,733.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.54% | 27.54% | 69.00% | -2,249.68% | -1,088.30% |
| Cash from Financing | 30.10% | 353.38% | 97.21% | 200.18% | 85.98% |
| Foreign Exchange rate Adjustments | -0.91% | -23.42% | -88.86% | 163.23% | 433.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.09% | 7,759.25% | 96.53% | 160.55% | 116.06% |